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Purpose: Gastritis is found to be one of the most common gastrointestinal diseases worldwide. However, current
therapeutic agents cause side effects, interaction, and recurrence. Allantoin has anti-inflammatory and wound healing
properties. In this study, the therapeutic effect of allantoin has been assessed on the histopathological indices and
gastric mucosal barrier of male rats.Methods:Male rats were equally divided into control, ethanol-induced gastritis,
and allantoin groups. The therapeutic groups consisted of gastritis plus 12.5 mg/kg allantoin, gastritis plus 25 mg/kg
allantoin, and gastritis plus 50 mg/kg allantoin groups. After 5 days of allantoin administration, the rats were
sacrificed and a part of their gastric tissue was maintained at −70 °C for prostaglandin E2 (PGE2) and non-protein
sulfhydryl (NP-SH) measurements. Another part was stained with hematoxylin and eosin and Masson’s trichrome.
Results: We found that Allantoin increased parietal and mucosal cell counts and mucosal thickness after gastritis
induction. In addition, the number of leukocytes and vessels decreased in both of the mucosal and the submucosal
layers. Allatoin improved gastric ulcer in all treatment groups. Gastric levels of PGE2 and NP-SH increased after
allantoin treatment. Conclusion: This study indicated that allantoin had a considerable effect on gastritis treatment,
which seems to result from the reinforcement of gastric mucosal barrier.
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Introduction
Gastric ulcer disease is identified by inflammation, ulcer, and cell loss in the epithelial layer of
the stomach, which can develop to the gastric perforation or even gastric neoplasia (2, 10). In
addition, gastric ulcer is one of the most prevalent gastrointestinal disorders throughout the
world (2). It has been demonstrated that an imbalance between the protective and risk factors
leads to gastritis (20). The risk factors for gastritis include smoking, stress, infection, frequent
use of non-steroidal anti-inflammatory drugs, and excessive consumption of alcohol (10, 15,
16). Nowadays, the classic treatment for this disease includes proton pump inhibitors, H2
receptor blockers, and anti-acids. However, some of these drugs have shown a lot of side
effects, interaction, and recurrence (15, 19). Therefore, many researchers attempt to find new
drugs or approaches for gastritis treatment. Herbal medications are one of the most attractive
compounds in this context.
Allantoin is one of the principal compounds in many plants, such as yam, Nelumbo
nucifera rhizome, sugar beet, and leguminous and is a natural, safe, and non-toxic
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compound (4, 6). The wound healing and tissue regeneration effects of allantoin have already
been well known (3, 14). It has also been reported that allantoin decreases IL-4, IL-5, Ig-E
levels, and the number of leukocyte cells in the ovalbumin-induced lung inflammation (11).
Florentino et al. (8) revealed that allantoin has anti-nociceptive and anti-inflammatory effects
on the formalin-induced nociception test. Moreover, it has been shown that allantoin activates
imidazoline I1-receptor (I1R) in animal and cell line studies (5, 22). Recent studies have
shown that allantoin affects metabolic functions. For example, Chung et al. (5) have stated
that allantoin alleviates obesity and hyperlipidemia via I1R activation in mice. In another
experiment, allantoin improved cognitive function and neurogenesis in the mice hippocam-
pus (1). Interestingly, da Silva et al. (7) have recently reported the gastroprotective effect of
allantoin on gastric ulcer in female mice. Based on these observations, we designed
experiments to study the treatment effect of allantoin on ethanol-induced gastritis in male rats.
Material and Methods
Reagents
Allantoin was purchased from Sigma Aldrich Chemical Co. (Lot. MKBB4594V; Sigma
Aldrich, Chemie GmbH, Steinheim,Germany) and was dissolved in saline.
Experimental procedures
In this study, 36 male Wistar rats (obtained from Academic Center for Education, Culture &
Research, Qom, Iran) weighing 200–250 g were used. The rats were housed in a temperature-
controlled room with 12-h light–dark cycles and free access to standard laboratory chow and
water. All the procedures followed were in accordance with the Guidelines for Animal Care
and Use at the Qom University of Medical Sciences (IR.MUQ.REC.1394.102).
The rats were randomly divided into six equal groups (N= 6): the control group, which
received 1 ml per oral (p.o) saline by gavage; gastritis group, in which the fasted rats received
100% ethanol (1 ml p.o by gavage, single dose) to induce gastritis (2); and allantoin group,
which received 50 mg/kg allantoin (1 ml p.o by gavage) to find out possible toxic effects. In the
next groups, rats received allantoin after gastritis induction in different doses. Gastritis plus
12.5 allantoin group (G-A-12.5) received 12.5 mg/kg allantoin [intragavage (i.g.)]. Gastritis
plus 25 allantoin group (G-A-25) received 25 mg/kg allantoin (i.g.) (11) and gastritis plus
50 allantoin group (G-A-50) received 50 mg/kg allantoin (i.g.) (11). Allantoin administration
was performed for 5 days consecutively (9). On the 6th day, the rats were anesthetized by
an intraperitoneal (i.p.) injection of 50 mg/kg of sodium thiopental and sacrificed (17). The
abdomen was excised through midline incision and the stomach was removed. A part of the
stomach was dissected and fixed in 10% buffered formaldehyde solution. Paraffin blocks were
then prepared for histopathological findings. Another part of the stomach was dissected and
kept at −70 °C for evaluation of PGE2 and non-protein sulfhydryl (NP-SH) levels.
Histological study
After a minimum of 24 h from fixation, the tissues were dehydrated by putting them in
ascending concentrations of ethanol solutions (30%, 50%, 70%, 90%, and 100%), then
washed with xylene and embedded in paraffin wax. Afterward, the samples were sectioned
with a microtome and stained with hematoxylin and Eosin (H&E) and Masson’s trichrome
stain, and mounted with Canada balsam. All sections were studied by Olympus light
microscope (CX23 LED Microscope, Japan). Photomicrographs of the stomach tissue were
326 Eslami-farsani et al.
Physiology International (Acta Physiologica Hungarica) 105, 2018
taken in 4×, 10×, and 40× magnification for observation and demonstration of histopatho-
logic lesions. Histological features assayed included mucosal thickness and ulcer area and the
number of leukocytes, parietal cells, mucosal cells and vessels. For this purpose, five sections
of each tissue sample were observed and in each section, four fields were evaluated by ImageJ
software (National Institutes of Health, ImageJ 1.49f, USA).
Tissue PGE2 measurement
Weighed samples of tissues (approximately 0.5 g) were homogenized in 2-ml microfuge
tubes by an electrical homogenizer (IKA-3420000, Germany). The supernatants were then
assayed for PGE2 levels using an immunometric enzyme immunoassay (EIA) kit according
to the manufacturer’s instruction (ADI-900-001).
NP-SH measurement
The content of gastric NP-SH was measured from supernatant obtained from 100-mg gastric
tissue in 1 ml of 0.02 M EDTA, distilled water, and trichloroacetic acid. The supernatants
were then mixed with Tris buffer and 5,5-ditiobis (2-nitrobenzoic acid), according to Shin
et al.’s method (19). The absorbance was measured at 412 nm and reported as μg/g of the
gastric tissue using the standard curve.
Statistical analysis
Data were expressed as mean± standard error of the mean. Statistical analysis was performed
by one-way analysis of variance and Tukey’s post hoc test using SPSS for Windows version
11.5 (IBM SPSS version 11.5; USA). p< 0.05 was considered to be statistically significant.
Results
Effect of allantoin on the mucosal thickness
The mucosal layer thickness was measured in millimeter (mm) from the mucosal muscle to
the apex of the epithelial cells at a magnification of 40× in four fields from the photomicro-
graph by software. For each sample, five sections were examined and their mean was
considered as the average thickness of the mucus layer. As shown in Figs 1a and 2, the
mucosal thickness significantly decreased in the gastritis group compared to the control group
(14.93± 1.74 vs. 27.85± 1.46, p< 0.01). However, allantoin administration increased
Fig. 1. (a) Mucosal layer thickness of the gastric tissue in different groups. Mean± SEM, N= 6, *p< 0.01 compared
to control. #p< 0.001 compared with gastritis group. (b) Leukocyte numbers of mucosal and submucosal layers in
different groups. Mean± SEM, N= 6, *p< 0.001 compared to control. #p< 0.001 compared to the gastritis group
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mucosal thickness in all treatment groups (G-A-12.5, allantoin, G-A-25 allantoin,
and G-A-50 allantoin groups; 37.66± 2.4, 36.4± 2.73, 31.16± 0.27 vs. 14.93± 1.74,
p< 0.001, respectively).
Effect of allantoin on the number of leukocytes
The obtained findings revealed that the leukocyte numbers in both of the mucosal and the
submucosal layers increased in the gastritis group compared to the control group (19.88±
2.6 vs. 5.77± 0.66, p< 0.001 and 16.11 ± 2.46 vs. 4.22± 0.32, p< 0.001, respectively).
However, the leukocyte numbers decreased in the G-A-12.5 allantoin group compared to the
gastritis group in both layers (5.66± 0.52 vs. 19.88± 2.6 and 6.11± 0.07 vs. 16.11± 2.46,
p< 0.001, respectively), whereas in other groups, no significant decreases were observed
(Fig. 1b).
Effect of allantoin on the ulcer areas
For the ulcer area measurement, the length and thickness of the ulcer in mm2 were measured
at a magnification of 40× with the software and the area of the gastric ulcer was obtained in
Fig. 2. Histopathological findings of the gastric tissue in different groups. (a–c) The control group: showing normal
mucosal layer of the gastric tissue. (d–f) The gastritis group: showing detachment and loss of mucosal layer (head of
arrow). (g–i) Treatment groups (12.5, 25, 50 mg allantoin, respectively): showing improvement of ulcers and increase
of mucosal layers (b, e: Masson’s trichrome, 4×), (a, c, d, f–i: H&E, 4×). MU: mucosal layer;
SM: submucosal layer; ME: muscular extern
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each section. Five sections were examined for each sample. Our results showed that
ulcer areas significantly increased in the gastritis group compared to the control group
(56.52± 10.6 vs. 0 mm2, p< 0.001). However, allantoin treatment significantly lowered ulcer
areas in the G-A-12.5 allantoin, G-A-25 allantoin, and G-A-50 allantoin groups compared to
the control group (24.81± 7.48, 10.6± 5.35, and 10.24± 2.65 vs. 56.52± 10.6, p< 0.001,
respectively; Fig. 3c).
Effect of allantoin on the number of the parietal and mucosal cells
For counting the cells, the average values of the cells at four microscopic fields in each
section were considered by the image J software at a magnification of 400× (Fig. 4). The
average number of cells in five stomach sections from each sample was considered as the
number of cells in that specimen.
Histological evaluations revealed that ethanol administration significantly decreased
the number of parietal and mucosal cells compared to the control group (1.55± 0.37 vs.
13.66± 0.78, p< 0.001 and 1.66± 0.55 vs. 6.88± 0.56, p< 0.001 respectively). Meanwhile,
the number of parietal cells increased in the G-A-12.5 allantoin, G-A-25 allantoin, and
G-A-50 allantoin groups compared to the gastritis group (14.22± 1.1, 9.66± 1.17, and
9.44± 0.74 vs. 1.55± 0.37, p< 0.001, respectively). Similarly, allantoin administration
increased the mucosal cells in the G-A-12.5 allantoin, G-A-25 allantoin, and G-A-50 allantoin
groups compared to the gastritis group (10.11± 1.79, 9.11± 0.71, and 6.8± 0.59 vs.
1.66± 0.55, p< 0.001, respectively; Figs 3a and 5).
Fig. 3. (a) Number of cells in different groups. Mean± SEM, N= 6, *p< 0.001 compared to the control group.
#p< 0.001 compared to the gastritis group. (b) Number of vessels of mucosal and submucosal layers in different
groups. Mean± SEM, N= 6, *p< 0.05 compared to control. #p< 0.05 compared to the gastritis group. (c) Ulcer
areas of the gastric tissue in different groups. Mean± SEM, N = 6, *p< 0.001 compared to control. #p< 0.001
compared to the gastritis group
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Effect of allantoin on the number of vessels
For counting lamina propria and submucosa vessels, similar to the cells counting,
100× magnification was used. As noted in Fig. 3b, gastritis markedly increased the
number of vessels in the mucosal layer compared to the control group (17.66 ± 6.06 vs.
1.66 ± 0.33, p = 0.01). However, the number of vessels significantly decreased in the
G-A-12.5 allantoin and G-A-25 allantoin groups compared to the gastritis group
(1.66 ± 0.88 and 1.66 ± 0.33 vs. 17.66 ± 6.06, p = 0.01). However, the vessel numbers
increased in the G-A-50 allantoin group.
Our findings also showed a significant increase in the gastritis group compared to the
control group in the vessel number of the submucosal layer (7± 0.57 vs. 3± 0.57, p= 0.004),
but allantoin administration significantly decreased it only in the G-A-12.5 allantoin group
compared to the gastritis group (4± 0.57 vs. 7± 0.57, p= 0.03).
Effect of allantoin on PGE2 levels
This study also revealed that gastric PGE2 levels significantly decreased in the gastritis
group compared to the control group (666.32 ± 56.46 vs. 1,533.25 ± 16.41, p < 0.001).
However, PGE2 levels showed a significant increase in the treatment groups (G-A-12.5,
Fig. 4. Histopathological findings of the inflammatory cells in the mucosal (white arrow) and submucosal layers
(head of black arrow) of different groups. Parietal cells (triangle), chief cells (wavy arrow). (a–c) The control group.
(d–f) The gastritis group: showing granulated tissue and fibrosis (thin arrow) and inflammatory cells.
(g–i) G-A-12.5, G-A-25, G-A-50 groups, respectively; less inflammation in G-A-12.5 group
(b, e: Masson’s trichrome, 10×; a, c, d, f–i: H&E, 4×; c, f: H&E, 40×)
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allantoin, G-A-25 allantoin, and G-A-50 allantoin groups) compared to the gastritis group
(956.12 ± 17.83, 1,499.62 ± 42.25, and 1,638.95 ± 21.31 vs. 666.32 ± 56.46 pg/mg,
p < 0.001, respectively; Fig. 6a).
Fig. 5. Histopathological findings of the gastric tissues in different groups. Parietal cells (triangle), chief cells (wavy
arrow), mucosal cells (thin arrow), and blood infiltration in submucosal layer (thick arrow). (a) The control group.
(b, c) the gastritis group: showing the mess of the tissue and loss of gland and cell numbers. (d–f) G-A-12.5, G-A-25,
G-A-50 groups; increase of glands and cell numbers, respectively (a–f: H&E, 40×)
Fig. 6. (a) PGE2 levels of the gastric tissue in different groups. Mean± SEM, N= 6, *p< 0.001 compared to control.
#p< 0.001 compared to the gastritis group. (b) NP-SH levels of the gastric tissue in different groups. Mean± SEM,
N= 6, *p< 0.001 compared to control. #p< 0.001 compared to the gastritis group
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Effects of allantoin on the gastric NP-SH levels
Our results showed that gastric contents of mucosal NP-SH significantly decreased in the
gastritis group compared to the control group (42.46± 1.48 vs. 71.0275± 2.34, p< 0.001).
However, allantoin treatment in the G-A-12.5 allantoin, G-A-25 allantoin, and G-A-50
allantoin groups significantly increased NP-SH levels compared to the gastritis group
(81.8875± 2.14, 81.3125± 1.26, and 64.745± 2.15 vs. 42.46± 1.48, p< 0.001, respectively;
Fig. 6b).
Discussion
The beneficial effects of allantoin on inflammation, oxidative activities, and wound healing
have been well known (8, 9). In this study, we showed that allantoin improved gastritis,
mucosal thickness, and cell numbers after ethanol-induced gastritis, decreased leukocyte,
and vessel numbers and increased the PGE2 and NP-SH levels in the gastric tissue of
male rats.
Long-term alcohol consumption is considered to be a risk factor for peptic ulcer, and
ethanol administration experimentally induces gastritis, mucosal layer hyperemia, mucosal
cell loss, and leukocyte infiltration in rats (3, 14, 18). Our results showed that ethanol
decreased the mucosal layer thickness, parietal, and mucosal cell numbers and NP-SH levels,
whereas allantoin treatment increased mucosal thickness, parietal, and mucosal cell counts and
NP-SH levels. Gastric mucosal barrier and bicarbonate rich mucus are the first defense line
against ulceration and it seems that allantoin treatment could increase mucosal cell number,
mucus secretion, and mucosal thickness and cause gastritis improvement. NP-SHs help to
maintain mucosal integrity and free radical scavenging. Increased NP-SH levels after allantoin
treatment probably provide mucosal thickness increment and gastritis healing. These findings
are also consistent with several reports, which demonstrated that silymarin and extract of
glutinous rice increased NP-SH levels and mucus contents and had gastroprotective effect on
the gastric ulcer (19, 20). The increased number of leukocyte cells is considered to be a sign of
inflammation in the tissue. Our findings revealed that in both mucosal and submucosal layers,
leukocyte cells increased in the gastritis group and allantoin administration led to decrement of
the leukocyte cell number. Vessel numbers also increased after ethanol use, whereas allantoin
decreased the number of vessels. It seems that increasing leukocyte and vessel numbers result
from inflammation and hyperemia induced by gastritis in the stomach (12). In this context, it
has been reported that allantoin decreased IL4, IL5, and inflammatory cell infiltration in
asthma-induced rats (11). Furthermore, da Silva et al. (7) have recently shown that allantoin
decreases TNFα and IL1β in gastritis induced in female mice. Our results are in agreement
with these documents and demonstrate anti-inflammatory effects of allantoin in the ethanol-
induced gastritis in male rats. However, in this study, leukocyte cell and vessel numbers
increased in G-A-50 allantoin compared to other treatment groups, which may be due to the
high dose of allantoin. In total, 12.5 mg/kg allantoin dose presented better results. Initially, we
selected 50 and 25 mg doses according to the study of Lee et al. (11). Afterward, because of
the positive results obtained, it was decided to use lower doses (12.5 mg). This is an important
point in the study showing fewer side effects at lower doses.
One of the prostaglandins in the gastric mucosa is PGE2. PGE2 enhances mucus
secretion, inhibits gastric acid secretion, and improves gastric ulcer (9, 13). As it has been
shown in many studies, our results also indicated that ethanol consumption led to PGE2
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decrease, and allantoin administration in gastritis groups was observed to increase PGE2
levels in the gastric tissue. Previously, it has been documented that allantoin increased the
activity of COXs production pathways (21, 23). Therefore, it is probable that increased
COX1 and COX2 synthesis will cause increased PGE2 secretion in the stomach tissue.
It seems that allantoin increases mucosal cells, followed by increased mucus secretion and
NP-SH levels. NP-SH compounds and PGE2 help to increase antioxidant defense, to keep on
mucus barrier integrity and thereby to improve gastritis.
Conclusions
This study revealed that allantoin had positive effects on the histopathological indices and
could promote and keep the gastric mucosal barrier in ethanol induced gastritis. Moreover, it
was found that 12.5-mg allantoin showed the best results after 5 days of consequent
treatment. This caused better results with the lower doses as shown. Therefore, allantoin
can help to decrease side effects of the agents and drug interactions.
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